Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS
We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients...
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 1993-12, Vol.17 (6), p.1070-1071 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1071 |
---|---|
container_issue | 6 |
container_start_page | 1070 |
container_title | Clinical infectious diseases |
container_volume | 17 |
creator | Wallace, Mark R. Nguyen, Minh-Thu Newton, James A. |
description | We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel. |
doi_str_mv | 10.1093/clinids/17.6.1070 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16790872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4457523</jstor_id><sourcerecordid>4457523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMoWqs_QFDYk7e1mc3mY4-lWisIVmxBvIRsNovRblOTFO2_N6Wlpxnmed85PAhdAb4DXJGBXtilbcIA-B1LF46PUA8o4TmjFRynHVORl4KIM3QewhfGAALTU3QqgAHhtIde5sFkrs2myrvOdRttl1nrfBY_TTbzRsXOLOM2MPKbVXRh5bxtrAs2ZCk5VdEmHrJfGz-z4dP92wU6adUimMv97KP5-GE2muTPL49Po-FzrolgMaea66IQJWOaKChAMFHTpqIlrjWAEa2ui1poraBpGOcECNG8YkXDecVJW5I-ut39XXn3szYhys4GbRYLtTRuHSQwXmHBixSEXVB7F4I3rVx52ym_kYDlVqLcS5TAJZNbialzs3--rjvTHBp7a4lf7_hXiM4fcFlSTguScL7DNkTzd8DKf0vGU19O3j_krCQjqF4_5Jj8A4Ofhww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16790872</pqid></control><display><type>article</type><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</creator><creatorcontrib>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</creatorcontrib><description>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/clinids/17.6.1070</identifier><identifier>PMID: 8161375</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>AIDS ; AIDS-Related Opportunistic Infections - complications ; AIDS-Related Opportunistic Infections - drug therapy ; Correspondence ; Cryptosporidiosis ; Cryptosporidiosis - complications ; Cryptosporidiosis - drug therapy ; Diarrhea ; Humans ; Paromomycin - administration & dosage ; Paromomycin - adverse effects ; Paromomycin - therapeutic use ; Vertigo - chemically induced ; Weight loss</subject><ispartof>Clinical infectious diseases, 1993-12, Vol.17 (6), p.1070-1071</ispartof><rights>Copyright 1993 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4457523$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4457523$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27903,27904,57995,58228</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8161375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wallace, Mark R.</creatorcontrib><creatorcontrib>Nguyen, Minh-Thu</creatorcontrib><creatorcontrib>Newton, James A.</creatorcontrib><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</description><subject>AIDS</subject><subject>AIDS-Related Opportunistic Infections - complications</subject><subject>AIDS-Related Opportunistic Infections - drug therapy</subject><subject>Correspondence</subject><subject>Cryptosporidiosis</subject><subject>Cryptosporidiosis - complications</subject><subject>Cryptosporidiosis - drug therapy</subject><subject>Diarrhea</subject><subject>Humans</subject><subject>Paromomycin - administration & dosage</subject><subject>Paromomycin - adverse effects</subject><subject>Paromomycin - therapeutic use</subject><subject>Vertigo - chemically induced</subject><subject>Weight loss</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhoMoWqs_QFDYk7e1mc3mY4-lWisIVmxBvIRsNovRblOTFO2_N6Wlpxnmed85PAhdAb4DXJGBXtilbcIA-B1LF46PUA8o4TmjFRynHVORl4KIM3QewhfGAALTU3QqgAHhtIde5sFkrs2myrvOdRttl1nrfBY_TTbzRsXOLOM2MPKbVXRh5bxtrAs2ZCk5VdEmHrJfGz-z4dP92wU6adUimMv97KP5-GE2muTPL49Po-FzrolgMaea66IQJWOaKChAMFHTpqIlrjWAEa2ui1poraBpGOcECNG8YkXDecVJW5I-ut39XXn3szYhys4GbRYLtTRuHSQwXmHBixSEXVB7F4I3rVx52ym_kYDlVqLcS5TAJZNbialzs3--rjvTHBp7a4lf7_hXiM4fcFlSTguScL7DNkTzd8DKf0vGU19O3j_krCQjqF4_5Jj8A4Ofhww</recordid><startdate>19931201</startdate><enddate>19931201</enddate><creator>Wallace, Mark R.</creator><creator>Nguyen, Minh-Thu</creator><creator>Newton, James A.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope></search><sort><creationdate>19931201</creationdate><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><author>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>AIDS</topic><topic>AIDS-Related Opportunistic Infections - complications</topic><topic>AIDS-Related Opportunistic Infections - drug therapy</topic><topic>Correspondence</topic><topic>Cryptosporidiosis</topic><topic>Cryptosporidiosis - complications</topic><topic>Cryptosporidiosis - drug therapy</topic><topic>Diarrhea</topic><topic>Humans</topic><topic>Paromomycin - administration & dosage</topic><topic>Paromomycin - adverse effects</topic><topic>Paromomycin - therapeutic use</topic><topic>Vertigo - chemically induced</topic><topic>Weight loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wallace, Mark R.</creatorcontrib><creatorcontrib>Nguyen, Minh-Thu</creatorcontrib><creatorcontrib>Newton, James A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wallace, Mark R.</au><au>Nguyen, Minh-Thu</au><au>Newton, James A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>1993-12-01</date><risdate>1993</risdate><volume>17</volume><issue>6</issue><spage>1070</spage><epage>1071</epage><pages>1070-1071</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>8161375</pmid><doi>10.1093/clinids/17.6.1070</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 1993-12, Vol.17 (6), p.1070-1071 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_proquest_miscellaneous_16790872 |
source | Jstor Complete Legacy; MEDLINE; Oxford University Press Journals Digital Archive Legacy |
subjects | AIDS AIDS-Related Opportunistic Infections - complications AIDS-Related Opportunistic Infections - drug therapy Correspondence Cryptosporidiosis Cryptosporidiosis - complications Cryptosporidiosis - drug therapy Diarrhea Humans Paromomycin - administration & dosage Paromomycin - adverse effects Paromomycin - therapeutic use Vertigo - chemically induced Weight loss |
title | Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T07%3A03%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Paromomycin%20for%20the%20Treatment%20of%20Cryptosporidiosis%20in%20Patients%20with%20AIDS&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Wallace,%20Mark%20R.&rft.date=1993-12-01&rft.volume=17&rft.issue=6&rft.spage=1070&rft.epage=1071&rft.pages=1070-1071&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/clinids/17.6.1070&rft_dat=%3Cjstor_proqu%3E4457523%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16790872&rft_id=info:pmid/8161375&rft_jstor_id=4457523&rfr_iscdi=true |